Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03370549
Other study ID # BostonUCRC
Secondary ID
Status Completed
Phase N/A
First received November 29, 2017
Last updated December 11, 2017
Start date August 1, 2013
Est. completion date July 31, 2017

Study information

Verified date December 2017
Source Boston University Charles River Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our objective for this R34 is to develop gender/culture specific and trauma informed group psychotherapy intervention designed to treat Chinese-, Korean-, and Vietnamese-American young women with histories of interpersonal violence trauma. The intervention is called Asian Women's Action for Resilience and Empowerment (AWARE).


Description:

Recent epidemiological studies document two emerging public health problems among Asian-Pacific Islander (API) women in the US:

1. A growing incidence of HIV/AIDS. Although the prevalence of HIV/AIDS among APIs is low compared to those among Blacks, Whites, and Hispanics, HIV infection among APIs significantly increased (44%) between 2004 and 2007. Additionally, 75% of HIV transmission among API women is through heterosexual intercourse, which is substantially higher than percentages among other racial/ethnic groups of women.

2. Poor mental health functioning exhibited by completed suicide rates. Young API women (ages 15 to 34) have not only the highest rates of completed suicide compared to other women of the same age in the US, but also experienced the largest growth in rates of suicide over the past decade.

Our preliminary studies using both quantitative and qualitative methods found strong links between past trauma and poor sexual and mental health outcomes. For API women, reporting a history of forced sex was associated with higher odds of severe depression, substance use, getting pregnant, and HIV risk behaviors compared to API women who did not report a history of forced sex. API women continue to be vulnerable given their lower rates of HIV testing, lower mental health utilization, and premature dropout rates in mental health treatment compared to other racial groups. So far, no existing intervention targets both sexual health and mental health problems among API women. Specifically, this study builds upon data on API women from prior NIMH-funded work as the foundation for our intervention.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date July 31, 2017
Est. primary completion date June 23, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- self-identify as female;

- are unmarried;

- are between the ages 18 and 35;

- are of Chinese, Korean, and/or Vietnamese descent;

- are 1.5 (immigrated to the US before the age of 18) or 2nd (US-born children of 1st generation immigrants) generation;

- are fluent in English;

- have a mobile phone with text messaging;

- have had penile-vaginal intercourse in their lifetime;

- have a history of exposure to at least one of five selected criteria in the Traumatic Life Events Questionnaire (TLEQ). These criteria include: beaten by stranger, death threat, childhood physical abuse, family violence, and partner physical assault;

Exclusion Criteria:

- at current significant risk of homicidal or suicidal behavior

- having symptoms of psychosis;

- have previously experienced natural disasters or other non-violent trauma;

- are of mixed race other than Korean-, Chinese-, or Vietnamese-Americans;

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
AWARE intervention
Group psychotherapy for Asian-American women

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Boston University Charles River Campus Rutgers University

References & Publications (9)

Augsberger A, Yeung A, Dougher M, Hahm HC. Factors influencing the underutilization of mental health services among Asian American women with a history of depression and suicide. BMC Health Serv Res. 2015 Dec 8;15:542. doi: 10.1186/s12913-015-1191-7. — View Citation

Hahm HC, Chang ST, Tong HQ, Meneses MA, Yuzbasioglu RF, Hien D. Intersection of suicidality and substance abuse among young Asian-American women: implications for developing interventions in young adulthood. Adv Dual Diagn. 2014;7(2):90-104. — View Citation

Hahm HC, Gonyea JG, Chiao C, Koritsanszky LA. Fractured Identity: A Framework for Understanding Young Asian American Women's Self-harm and Suicidal Behaviors. Race Soc Probl. 2014;6(1):56-68. — View Citation

Hahm HC, Jang J, Vu C, Alexander LM, Driscoll KE, Lundgren L. Drug use and suicidality among Asian American women who are children of immigrants. Subst Use Misuse. 2013 Dec;48(14):1563-76. doi: 10.3109/10826084.2013.808219. Epub 2013 Jul 12. — View Citation

Hahm HC, Kolaczyk E, Lee Y, Jang J, Ng L. Do Asian-American women who were maltreated as children have a higher likelihood for HIV risk behaviors and adverse mental health outcomes? Womens Health Issues. 2012 Jan-Feb;22(1):e35-43. doi: 10.1016/j.whi.2011.07.003. Epub 2011 Aug 26. — View Citation

Hahm HC, Lee CH, Choe JY, Ward A, Lundgren L. Sexual Attitudes, Reasons for Forgoing Condom Use, and the Influence of Gender Power among Asian-American Women: A Qualitative Study. J AIDS Clin Res. 2011 Dec 30;(S1). pii: 004. — View Citation

Hahm HC, Lee J, Chiao C, Valentine A, Lê Cook B. Use of Mental Health Care and Unmet Needs for Health Care Among Lesbian and Bisexual Chinese-, Korean-, and Vietnamese-American Women. Psychiatr Serv. 2016 Dec 1;67(12):1380-1383. Epub 2016 Jul 1. — View Citation

Hahm HC, Lee J, Rough K, Strathdee SA. Gender power control, sexual experiences, safer sex practices, and potential HIV risk behaviors among young Asian-American women. AIDS Behav. 2012 Jan;16(1):179-88. doi: 10.1007/s10461-011-9885-2. — View Citation

Lee J, Hahm HC. HIV risk, substance use, and suicidal behaviors among Asian American lesbian and bisexual women. AIDS Educ Prev. 2012 Dec;24(6):549-63. doi: 10.1521/aeap.2012.24.6.549. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change in PTSD Symptoms The PTSD Checklist, Civilian version (PCL-C) is a 17-item self-report measure of PTSD symptom severity. Each item corresponds to a PTSD symptom outlined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Participants reported both the frequency and intensity of their experiences of PTSD symptoms over the past three months on a 5-point scale ranging from low to high. Symptom severity was computed by summing the frequency and intensity scores. Total scores ranged from 17 to 85, with a score of 50 used as the cutoff to assess a diagnosis of PTSD. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Other Change in Safety Outcome The Columbia-Suicide Severity Rating Scale (C-SSRS) was used to assess history of suicidal ideation and suicidal intent. Participants who reported yes to either one of the following questions were classified as having suicidal ideation--wished to be dead, thought of killing yourself, and thought about how to do this. Suicidal intent was measured with answering yes to either one of having intention of acting on thoughts of killing yourself as well as having worked out the details of how to do it. At baseline (T0), lifetime suicidal outcomes were measured and. For the post intervention evaluations (T1, T2), suicidal outcomes of the past 30 days were measured. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Other Change in HIV Knowledge The HIV-Knowledge Questionnaire (HIV-KQ) is a 45-item assessment on knowledge pertaining to HIV. Statements are responded to in a true/false/don't know format, addressing topics of prevention (i.e. safe sex practices), transmission (i.e. sexual transmission and other modes) and consequences (i.e. testing and treatment). The HIV-KQ exhibits a high internal consistency, with Cronbach's alpha = 0.91. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Other Change in Self-Efficacy Scale The Self-efficacy Scale for Limiting HIV Risk Behaviors (LHRB) contains 9 statements on self-efficacy pertaining to HIV risk behaviors. Participants are asked to rate how sure they are that they could perform each statement (0= not sure at all to 4=very sure). Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Other Feasibility Outcome Participant retention was evaluated using the number of sessions attended. The "completers" of the intervention were defined as those who attended at least 80% of the sessions. Similar definitions have been used in other studies. 8 weeks of treatment
Primary Change in Sexual Risk Behaviors AIDS Risk Behavior Assessment (ARBA) was used. Sexual risk behaviors were defined as engaging in unprotected sex, having multiple sex partners, and engaging in anal sex. Engagement in unprotected sex was assessed by asking participants, "Of those times that you had vaginal sex in the past three months, how often did you or your partner use condoms/latex protection?'' Responses were scored 0 for "never used a condom," "some of the time," "half of the time," "more than half of the time" and 1 for "every time." Having multiple sex partners was assessed by the question: "How many female/male sex partners have you had in the past three months?" Responses were coded dichotomously as 0 for none or one sexual partner and 1 for more than one sexual partner. Engagement in anal sex was assessed by the question, "How many times in the past three months did you have anal sex?" Responses were dichotomized as 0 for none, and 1 for one or more times. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Secondary Change in Depressive Symptoms The Center for Epidemiological Studies Depression Scale (CES-D) is a 20-item self-report questionnaire designed to assess depressive symptomatology. For each item, participants reported their status over the past two weeks using a Likert-type scale ranging from rarely or never (0) to most days or always (3). Responses were summed to create a total symptom score ranging from 0 to 60. The CES-D has demonstrated very high internal consistency, reliability and validity. The internal consistency of our sample ranged from .86 to .92. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Secondary Change in Substance Use Addiction Severity Index (ASI) is a self-report questionnaire for patients who present for substance abuse treatment. The instrument gathers information about seven areas of a patients life: medical, employment/support, drug and alcohol use, legal, family history, family/social relationships. The scale has Cronbach's alpha of alcohol section of 0.75 and for Drug section is 0.70. This measure was used in testing SS for women who suffered from substance use and PTSD. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
Secondary Change in Mental Distress The General Mental Distress Index (GMDI) is a 21-item scale screening for symptoms of depression, anxiety, suicidal ideation, and other aspects of mental and emotional distress. Each item is scored 1 for "yes" and 0 for "no." A score of 4-6 indicates clinically-significant symptoms, and a score of 7+ indicates acute distress with the possibility of reoccurring mental health problems. Outcomes will be measured at: baseline, up to 12 weeks after the baseline, 3 months post intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05639855 - Study on Mental Health-related Stigma N/A
Completed NCT03042832 - Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention N/A
Completed NCT03007940 - Using NIATx Strategies to Implement Integrated Services in Routine Care N/A
Active, not recruiting NCT05726617 - Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders N/A
Active, not recruiting NCT04090723 - Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum N/A
Enrolling by invitation NCT05523843 - Pilot Study on the Clinical Utility of the Tulsa Life Chart
Recruiting NCT04299789 - Military Service Identification Tool
Recruiting NCT05258578 - Tele-BARICARE to Manage COVID-19-Related Distress N/A
Recruiting NCT06190184 - Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions N/A
Completed NCT04649736 - Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients N/A
Not yet recruiting NCT05097807 - The Impact of Shallow Reading in Social Media N/A
Active, not recruiting NCT03013595 - The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care N/A
Active, not recruiting NCT05092542 - Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers N/A
Completed NCT05274958 - Effectiveness of Telepsychiatry With Randomized Waitlist Control Utilizing Patient Reported Outcome Measures N/A
Completed NCT05303870 - Impact of Psychological Therapies on Emergency Medical Patients N/A
Recruiting NCT04841655 - Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Completed NCT05213182 - Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe Phase 2
Completed NCT05638516 - Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digital Preventative Product N/A
Completed NCT06311084 - IMAGINATOR 2.0: Co-design and Early Evaluation of a Novel Blended Digital Intervention Targeting Self-harm in Young People N/A
Active, not recruiting NCT04600414 - Collaborating to Heal Addiction and Mental Health in Primary Care N/A